Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients

American Journal of Nephrology

Volumn 18, Issue 5, 1998, Pages 416-421

  Elisaf, Moses ^a   Bairaktarf, Eleni ^a   Katopodis, Kostas ^a   Pappas, Michael ^a   Sferopoulos, George ^a   Tzallas, Christos ^a   Tsolas, Orestes ^a   Siamopoulos, Kostas C ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Dyslipidemia; Hemodialysis; Hypertriglyceridemia; L carnitine

Indexed keywords

ACETIC ACID; BICARBONATE; BUFFER; CARNITINE; CUPROPHANE; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DIALYSIS MEMBRANE; DIET SUPPLEMENTATION; FEMALE; GREECE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LONG TERM CARE; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEINS; BUFFERS; CARNITINE; CHOLESTEROL; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; HYPERTRIGLYCERIDEMIA; KIDNEY FAILURE, CHRONIC; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 0031693059     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013386     Document Type: Article

References (37)

1. Lazarus JM, Lowry EG, Hampers CL, Merrill P: Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 1975;7(suppl 2):167-175.
2. Linder AL, Charra B, Sherrard DJ, Scribner BN: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
3. Attman P, Samuelsson O, Alaupovic P: Lipoprotem metabolism and renal failure. Am J Kidney Dis 1993;21:573-592.
4. Chan MK, Varghese Z, Moorhead JF: Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 1981;19:625-637.
5. Cattran DC, Steiner G, Wilson DR, Fenton SSA: Defective triglyceride removal in lipidemia associated with peritoneal dialysis and hemodialysis. Ann Intern Med 1976;85:29-33.
6. Chan MK, Persuad JW, Varghese Z, Moorhead JF: Pathogenic roles of postheparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 1984;25:812-816.
7. Bohmer T, Bergrem J, Eiklid K: Carnitine deficiency induced during intermittent hemodialysis for renal failure. Lancet 1978;i:126-128.
8. Corsi M: Secondary carnitine deficiency in renal dialysis; in Borum PR (ed): Clinical Aspects of Human Carnitine Deficiency. New York, Pergamon Press, 1986, pp 185-203.
9. Fritz JB: Carnitine and its role in fatty acid metabolism. Adv Lipid Res 1963;1:285-334.
10. Mitchell ME: Carnitine metabolism in human subjects. I. Normal metabolism. Am J Clin Nutr 1978;31:293-306.
11. Gusmano R, Oleggini R, Perfumo F: Plasma carnitine concentration and dyslipidemia in children on maintenance hemodialysis. J Pediatr 1981;99:429-432.
12. Bertoli M, Battistella PA, Vergani L, Naso A, Gasparotto ML, Romagnoli GF, Angelini C: Carnitine deficiency induced during hemodialysis and hyperlipidemia: Effect of replacement therapy. Am J Clin Nutr 1981;34:1496-1500.
13. Maebashi M, Imamura A, Yoshinaga K, Sato T, Funyu T, Ishidoya Y, Hirayama N: Camitine depletions as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis. Tohoku J Exp Med 1983;139:33-42.
14. Chan MK, Persaud JW, Varghese Z, Baillod RA, Moorhead JF: Response patterns to D,L-carnitine in patients on maintenance haemodialysis. Nephron 1982;30:240-243.
15. Guarnieri GF, Ranieri F, Toigo G, Vasile A, Ciman M, Rizzoli V, Moracchiello M, Campanacci L: Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Am J Clin Nutr 1980; 33:1489-1492.
16. Bougneres PF, Lacour B, Di Giulio S, Assan R: Hypolipaemic effect of carnitine in uraemic patients. Lancet 1979;1:1401-1402.
17. Lacour B, Di Giulio S, Chanard J, Ciancioni C, Haguet M, Lebkiri B, Basile C, Drucke T, Assan R, Funk-Brentano JL: Carnitine improves lipid anomalies in haemodialysis patients. Lancet 1980;ii:763-765.
18. Alvertazzi A, Capelli P, DiPaolo B, Pola P, Tondi P, Vaccario O: Endocrine-metabolic effects of L-carnitine in patients on regular dialysis treatment. Proc Eur Dial Transplant Assoc 1982;19:302-307.
19. Vacha GM, Giorcelli G, Siliprandi N, Corsi M: Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: Decisive role of low levels of high-density lipoprotein-cholesterol. Am J Clin Nutr 1983;38: 532-540.
20. Caruso U, Cravotto E, Tisone G, Elli M, Stortoni F, D'Iddio S, Pola P, Savi L, Tondi P, Castani CU: Long-term treatment with L-carnitine in uremic patients undergoing hemodialysis: Effects on the lipid pattern. Curr Ther Res 1983;33:1098-1103.
21. Casciani CV, Caruso U, Cravotto E, D'Iddio S, Corsi M, Pola P, Savi L, Grilli M: L-Carnitine in haemodialysis patients. Arzneimittelforschung 1982;32:293-297.
22. Suzuki Y, Narita M, Yamazaki N: Effects of L-carnitine on arrhythmias during hemodialysis. Jpn Heart J 1982;23:349-359.
23. Bellinghieri G, Savica V, Mallamace A, Di Stefano C, Consolo F, Spagnoli LG, Villaschi S, Palmieri G, Corsi M, Maccari F: Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983; 38:523-531.
24. Yderstraede KB, Pederson FB, Dragsholt C, Trostman A, Laier E, Larsen HF: The effect of L-carnitine on lipid metabolism in patients on chronic haemodialysis. Nephrol Dial Transplant 1987;1:238-241.
25. Nilsson-Ehle P, Cederblad G, Fagher B, Monti M, Thysell H: Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: Lack of effect of L-carnitine supplementation. Scand J Clin Lab Invest 1985;45: 179-184.
26. Aubia J, Masramon J, Lloveras J, Llorach M, Andolz P: Carnitine in hacmodialysis patients (letter). Lancet 1980;ii:1028-1029.
27. Weschler A, Aviram M, Levin M, Better OS, Brook JC: High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis. Nephron 1984;38:120-124.
28. Wanner C, Forstner-Wanner S. Schaeffer G, Schollmeyer P, Horl WH: Serum-free carnitine, carnitine esters and lipids in patients on peritoneal and hemodialysis. Am J Nephrol 1986;6:206-211.
29. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
30. Silberman SR, Armentrout MA, Vella FA, Saha AL: Macra™ Lp(a) for quantitation of human lipoprotein (a) by enzyme-linked immunoassay (abstract). Clin Chem 1990;36: 361.
31. Rossle C, Kohse KP, Franz HE, Furst P: An improved method for the determination of free and esterified carnitine. Clin Chim Acta 1985; 149:263-268.
32. Chan MK, Varghese Z, Persaud JW, Moorhead JF: Carnitine in haemodialysis patients. Lancet 1980;ii:1028-1029.
33. Guamieri G, Toigo G, Crapesi L, Situlin R, Del Bianco MA, Corsi M, LoGreco P, Paviotti G, Mioni G, Campanacci L: Carnitine metabolism in chronic renal failure. Kidney Int 1987; 22(suppl):116-127.
34. Zilleruelo G, Novak M, Hsia SL, Goldberg R, Abitbol C, Monkus E, Strauss J: Effect of dialysate composition on the lipid response to L-carnitine supplementation. Kidney Int 1989;36 (suppl 27):259-263.
35. Wanner C, Wieland H, Wackerle B, Boeckle H, Schollmeyer P, Hori WH: Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. Kidney Int 1989;36(suppl 27):264-268.
36. Golper TA, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 1990;38:904-911.
37. Vacha GM, Giorcelli G, D'Iddio S, Corsi M: Effects of long-term treatment with L-camitine on the lipid pattern of patients undergoing haemodialysis. Proc Eur Dial Transplant Assoc 1985;22:121-126.